BioNTech SEBNTXNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank47
3Y CAGR-56.5%
5Y CAGR-55.5%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-56.5%/yr
Quarterly compound
5Y CAGR
-55.5%/yr
Consistent
Percentile
P47
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 0.88% |
| Q2 2025 | -2.74% |
| Q1 2025 | -2.52% |
| Q4 2024 | 1.32% |
| Q3 2024 | -0.62% |
| Q2 2024 | -3.36% |
| Q1 2024 | -2.52% |
| Q4 2023 | 2.76% |
| Q3 2023 | -0.17% |
| Q2 2023 | -8.52% |
| Q1 2023 | 9.93% |
| Q4 2022 | 14.94% |
| Q3 2022 | 10.62% |
| Q2 2022 | 6.00% |
| Q1 2022 | 25.91% |
| Q4 2021 | 17.76% |
| Q3 2021 | 83.91% |
| Q2 2021 | 116.77% |
| Q1 2021 | 79.07% |
| Q4 2020 | 48.87% |
| Q3 2020 | 50.07% |
| Q2 2020 | 28.62% |
| Q1 2020 | -6.63% |
| Q4 2019 | 18.87% |
| Q3 2019 | 8.30% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |